ICYMI, this week we had articles about higher response rates were observed in HS patients treated with lutikizumab, a placebo-controlled study of cryosim-1 in prurigo nodularis, industry recommendations for drug products containing benzene, and more.
A meta-analysis revealed that a post-operative care routine that involves psychological well-being leads to improved patient outcomes.
Higher response rates were observed in patients treated with lutikizumab. The drug will now advance to phase 3 clinical trials.
The topical therapy was more effective in patients with psoriasis and AD when compared to a vehicle control cream.
Researchers analyzed the characteristics of Wood's lamp and reflective confocal laser scanning microcopy in guiding vitiligo staging.
Systemic corticosteroids are often used as primary therapy for PG, but alternatives should be considered for their favorable safety profile.
This week’s collection of the latest dermatologic studies covers ligelizumab for the treatment of chronic spontaneous urticaria, AI for the early detection of skin cancer, blood pressure monitoring for minoxidil therapy in alopecia patients, and aminolevulinic acid 20% solution plus blue light PDT for the treatment of AKs.
Dermatology Times is excited to ring in 2024 with a fresh perspective to amplify our impact, foster creativity, and deliver even more exceptional, compelling content to you—our cherished audience.
A randomized, placebo-controlled trial of the selective transient receptor potential melastatin 8 agonist explored its efficacy and safety in PN.
Researchers compared the quality of life, anxiety, depression, sleep disturbance, and other associated factors between patients with alopecia areata and vitiligo.
Test your knowledge and explore a recent study on the relationship between alcohol consumption and skin diseases, including atopic dermatitis.
Study findings suggest that Lavandula species, with their historical use in folk medicine, could emerge as valuable additions to AD treatment regimens. However, it's crucial to note that the efficacy of these oils is concentration-dependent.
Researchers said this data is demonstrative of VYN201's positive effects on multiple vitiligo-related biomarkers.
Winter Editor in Chief Christopher Bunick, MD, PhD, looks ahead to a year of dermatology innovations with a reflection on meaningful advances from 2023.
In this week’s Pointers With Portela, the 208SkinDoc reviews 7 different methods to treat acne without isotretinoin.
The integration of digital tools, including telemedicine, into routine clinical care is not without its hurdles.
Researchers say that application of these findings in clinical settings could enhance treatment optimization.
To gauge the impact and evolving landscape of HS treatment post-secukinumab approval, Spherix Global Insights conducted research with more than 100 US dermatologists.
Currently, some United States Pharmacopeia carbomer monographs allow unacceptable levels of benzene
Researchers found that high levels of AST and ALT in patients with acne taking oral isotretinoin was low in incidence.
The additional efficacy data highlights tapinarof cream 1% and its impact on EASI, PP-NRS, ViGA-AD, and more.
Innovative practice pearls for both vitiligo and atopic dermatitis treatment were shared with nearly 200 clinicians to put into practice at the virtual Revolutionizing Vitiligo and Revolutionizing Atopic Dermatitis Conferences.
Identifying the underlying cause of hair thinning or loss is often a diagnosis of exclusion.
Click here to answer our poll.
Patients may be at risk of bone damage from topical corticosteroids as well as systemic corticosteroids, according to a large study from Taiwan.
The study explored the use of the ointment in an area of 100 cm squared.
This article will discuss insights from research studies and offer specialized guidance aimed at dermatologists in hopes of fostering patient adherence in acne management.
When examining Ezra’s skin, you note well-defined erythematous scaly plaques with well-defined, serpiginous, raised borders and yellow crusting on the anterior shins and forearms.
Among the many sessions to be held at the 2024 Winter Clinical Dermatology Conference in Honolulu, Hawaii, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.
This is the first known meta-analysis to review the association between extent of smoking androgenetic alopecia.
Ten posters at the Winter Clinical Hawaii and Maui Derm Conferences will showcase investigational data to expand treatment options for patients with atopic dermatitis and chronic hand eczema.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.